Diabetes, advanced glycation endproducts and vascular disease

Wautier, J-L.; Guillausseau, P-J.
May 1998
Vascular Medicine;1998, Vol. 3 Issue 2, p131
Academic Journal
The high incidence of vascular complications in patients with diabetes mellitus remains incompletely understood. Several metabolic or endocrine abnormalities have been postulated as possible triggers for micro and macroangiopathies. This review article focuses on the consequences of hyperglycemia, leading to the formation of advanced glycation endproducts (AGE), on vascular function. Advanced glycation endproducts are the product of the binding of aldoses onto free amino groups of proteins or lipoproteins, which, after molecular rearrangement, result in a class of molecules of a brown color and specific fluorescence. Different cell membrane proteins have been shown to bind AGE and the best characterized receptor for AGE has been named RAGE. The AGE receptor is present on different cell types including endothelial cells, smooth muscle cells, lymphocytes and monocytes. Experimental studies have revealed that the binding of AGE to RAGE produces an activation of monocytes and endothelial cells. Activated endothelial cells produce interleukin and express vascular cell adhesion molecule and tissue factor. Advanced glycation endproducts, when infused into animals, induce an increase in vascular permeability. The blockade of RAGE by specific antibodies corrects the hypermeability observed in diabetic animals. The prevention of AGE formation by aminoguanidine treatment improves the microvascular lesions found in diabetic animals either in the retina or the glomerus. The infusion of recombinant RAGE in diabetic animals corrects hyperpermeability. The colocalization of RAGE and AGE at the microvascular site of the injury suggests that their interaction may play a significant role in the pathogenesis of diabetic vascular lesions.


Related Articles

  • Diabetes complications.  // Nursing Standard;2/25/2009, Vol. 23 Issue 25, p58 

    The article presents a quiz about the complications of diabetes including questions on blood vessel damage, ketoacidosis, and the stages of retinopathy.

  • Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Khan, Faisel; Elhadd, Tarik A.; Greene, Stephen A.; Belch, Jill J.F.; Khan, F; Elhadd, T A; Greene, S A; Belch, J J // Diabetes Care;Feb2000, Vol. 23 Issue 2, p215 

    Objective: Vascular disease in type 1 diabetes is a complex and multifactorial process, which probably begins in childhood in association with the onset of diabetes. To determine the possible factors involved, we measured microvascular responses to endothelium-dependent...

  • Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Jude, Edward B.; Oyibo, Samson O.; Chalmers, Nicholas; Boulton, Andrew J.M.; Jude, E B; Oyibo, S O; Chalmers, N; Boulton, A J // Diabetes Care;Aug2001, Vol. 24 Issue 8, p1433 

    Objective: The aim of this study was to quantify the distribution of peripheral arterial disease in the diabetic and nondiabetic population attending for angiography and to compare severity and outcome between both groups of patients.Research Design and Methods:...

  • The Webscout. Eichele, Karin // Medical Writing;Dec2012, Vol. 21 Issue 4, p313 

    The article discusses diabetes as a metabolic disease leading to secondary micro- and macro vascular complications and how affects the patient's psychological state. It states that anxiety, depression and eating disorders can usually be treated effectively but tend to recur. It also mentions...

  • Potential application of photoplethysmography technique in evaluating microcirculatory status of... Lee, Thay Q.; Barnett, Steven L. // Journal of Rehabilitation Research & Development;Fall90, Vol. 27 Issue 4, p363 

    Investigates the potential of photoplethysmography (PPG) as a method for assessing the level of cutaneous circulation and healing potential in patients who have to undergo lower extremity amputations due to diabetes mellitus and peripheral vascular diseases. Background on the study; Comparison...

  • Percutaneous Transluminal Cryoplasty Therapy. Blume, Peter; Sumpio, Bauer; Aruny, John; Sarage, Anthony // Podiatry Management;Nov/Dec2005, Vol. 24 Issue 9, p208 

    Provides information on CryoPlasty Therapy, an outgrowth of percutaneous angioplasty designed for the clinical management of peripheral arterial disease (PAD) in diabetic patients. Overview of PAD epidemiology; Basics of vascular imaging; Essentials of CryoPlasty Therapy; Methods of testing the...

  • EPO Clearly Increases Vascular Events in Diabetic PD Patients.  // Kidney;May/Jun99, Vol. 8 Issue 3, p117 

    Discusses the abstract of a study entitled `Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis,' by M. Wakeem, S.W. Zimmerman, published in the 1998 'American Journal of Kidney Diseases.'

  • Centrum diabetologie a diabetologický program v IKEM. PELIKÁNovÁ, TEREZIE; SAUDEK, F. // General Practitioner / Prakticky Lekar;Jan2011, Vol. 91 Issue 1, p11 

    Diabetes mellitus is undoubtedly one of the socially most important diseases with significant health and economic impacts. Every 15 years the number of registered diabetes nearly doubled and the problem is particularly long-term development of micro-and macrovascular complications. In the Czech...

  • Increased Incorporation of Antiplasmin Into the Fibrin Network in Patients With Type 1 Diabetes. Ågren, Anna; Jörneskog, Gun; Elgue, Graciela; Henriksson, Peter; Wallen, Håkan; Wiman, Björn // Diabetes Care;Jul2014, Vol. 37 Issue 7, p2007 

    OBJECTIVE Diabetes is associated with various vascular complications and is suggested to induce a prothrombotic state. In the current study, we characterized antiplasmin incorporation into fibrin in relation to other fibrinolytic compounds in patients with type 1 diabetes. RESEARCH DESIGN AND...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics